The 2026 Nobel Prize in Physiology or Medicine is awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel for developing optogenetics, a method that uses light to control individual nerve cells in the brain. Multiple outlets report the prize was announced on Monday and credits the scientists for work that enables researchers to switch targeted cells on and off with light, opening new ways to study brain circuits.

Several sources describe the scientific pathway behind the discovery, linking it to light-sensing proteins found in organisms such as algae. They say later advances included identifying light-gated ion channels (often associated with channelrhodopsins) and using genetic techniques to introduce light-sensitive proteins into neurons, allowing experiments in animals to control specific neural pathways. Outlets also note that optogenetics has helped researchers map how the brain processes information and has improved understanding of neurological and psychiatric conditions. Coverage varies on emphasis: some focus on brain mapping and circuit-level research, while others highlight potential applications, including better insight into disorders such as Parkinson’s, epilepsy, depression and schizophrenia, and experimental approaches such as restoring vision in certain retinal diseases.